• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

在致幻茶 ayahuasca 中发现的 N,N-二甲基色胺化合物,可调节体外和体内成年神经发生。

N,N-dimethyltryptamine compound found in the hallucinogenic tea ayahuasca, regulates adult neurogenesis in vitro and in vivo.

机构信息

Institute for Biomedical Research "A. Sols" (CSIC-UAM). Arturo Duperier 4, 28029, Madrid, Spain.

Spanish Center for Networked Biomedical Research on Neurodegenerative Diseases (CIBERNED), c/ Valderrebollo 5, 28031, Madrid, Spain.

出版信息

Transl Psychiatry. 2020 Sep 28;10(1):331. doi: 10.1038/s41398-020-01011-0.

DOI:10.1038/s41398-020-01011-0
PMID:32989216
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7522265/
Abstract

N,N-dimethyltryptamine (DMT) is a component of the ayahuasca brew traditionally used for ritual and therapeutic purposes across several South American countries. Here, we have examined, in vitro and vivo, the potential neurogenic effect of DMT. Our results demonstrate that DMT administration activates the main adult neurogenic niche, the subgranular zone of the dentate gyrus of the hippocampus, promoting newly generated neurons in the granular zone. Moreover, these mice performed better, compared to control non-treated animals, in memory tests, which suggest a functional relevance for the DMT-induced new production of neurons in the hippocampus. Interestingly, the neurogenic effect of DMT appears to involve signaling via sigma-1 receptor (S1R) activation since S1R antagonist blocked the neurogenic effect. Taken together, our results demonstrate that DMT treatment activates the subgranular neurogenic niche regulating the proliferation of neural stem cells, the migration of neuroblasts, and promoting the generation of new neurons in the hippocampus, therefore enhancing adult neurogenesis and improving spatial learning and memory tasks.

摘要

N,N-二甲基色胺(DMT)是一种成分的 ayahuasca 酿造传统上用于仪式和治疗目的在几个南美国家。在这里,我们已经研究了,在体外和体内,潜在的神经发生作用的 DMT。我们的研究结果表明,DMT 管理激活的主要成年神经发生小区,亚颗粒区齿状回的海马,促进新生成的神经元在颗粒区。此外,这些老鼠表现更好,与对照非治疗动物,在记忆测试,这表明了一个功能相关性的 DMT 诱导的新生产的神经元在海马。有趣的是,神经发生作用的 DMT 似乎涉及信号通过 sigma-1 受体(S1R)激活由于 S1R 拮抗剂阻断了神经发生的影响。总之,我们的研究结果表明,DMT 治疗激活亚颗粒神经发生小区调节增殖的神经干细胞,迁移的神经母细胞,并促进生成新的神经元在海马,因此增强成年神经发生和改善空间学习和记忆任务。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/225c/7522265/0e8b648ad017/41398_2020_1011_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/225c/7522265/74872b85fddc/41398_2020_1011_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/225c/7522265/bd0b23a3bd9a/41398_2020_1011_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/225c/7522265/340af03026cb/41398_2020_1011_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/225c/7522265/4cc28ebd3ae3/41398_2020_1011_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/225c/7522265/0e8b648ad017/41398_2020_1011_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/225c/7522265/74872b85fddc/41398_2020_1011_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/225c/7522265/bd0b23a3bd9a/41398_2020_1011_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/225c/7522265/340af03026cb/41398_2020_1011_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/225c/7522265/4cc28ebd3ae3/41398_2020_1011_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/225c/7522265/0e8b648ad017/41398_2020_1011_Fig5_HTML.jpg

相似文献

1
N,N-dimethyltryptamine compound found in the hallucinogenic tea ayahuasca, regulates adult neurogenesis in vitro and in vivo.在致幻茶 ayahuasca 中发现的 N,N-二甲基色胺化合物,可调节体外和体内成年神经发生。
Transl Psychiatry. 2020 Sep 28;10(1):331. doi: 10.1038/s41398-020-01011-0.
2
Metabolism and disposition of N,N-dimethyltryptamine and harmala alkaloids after oral administration of ayahuasca.口服安非他命和 harmala 生物碱后 N,N-二甲基色胺的代谢和处置。
Drug Test Anal. 2012 Jul-Aug;4(7-8):610-6. doi: 10.1002/dta.1344. Epub 2012 Apr 19.
3
Dimethyltryptamine: Endogenous Role and Therapeutic Potential.二甲色胺:内源性作用和治疗潜力。
J Psychoactive Drugs. 2019 Sep-Oct;51(4):299-310. doi: 10.1080/02791072.2019.1602291. Epub 2019 Apr 25.
4
Psychedelic Therapy: A Primer for Primary Care Clinicians-N,N-Dimethyltryptamine and Ayahuasca.迷幻疗法:初级保健临床医生指南-N,N-二甲基色胺和瓜拉那。
Am J Ther. 2024;31(2):e112-e120. doi: 10.1097/MJT.0000000000001725.
5
The alkaloids of Banisteriopsis caapi, the plant source of the Amazonian hallucinogen Ayahuasca, stimulate adult neurogenesis in vitro.卡皮木中的生物碱能刺激体外培养的成体神经发生。卡皮木是亚马逊致幻剂阿亚胡斯卡的植物来源。
Sci Rep. 2017 Jul 13;7(1):5309. doi: 10.1038/s41598-017-05407-9.
6
Impact of Two Neuronal Sigma-1 Receptor Modulators, PRE084 and DMT, on Neurogenesis and Neuroinflammation in an Aβ-Injected, Wild-Type Mouse Model of AD.两种神经元σ1 受体调节剂 PRE084 和 DMT 对 APP/PS1 转基因 AD 模型小鼠神经发生和神经炎症的影响。
Int J Mol Sci. 2022 Feb 24;23(5):2514. doi: 10.3390/ijms23052514.
7
Autonomic, neuroendocrine, and immunological effects of ayahuasca: a comparative study with d-amphetamine.安非他命的比较研究:迷幻剂致自主神经、神经内分泌和免疫效应
J Clin Psychopharmacol. 2011 Dec;31(6):717-26. doi: 10.1097/JCP.0b013e31823607f6.
8
Administration of N,N-dimethyltryptamine (DMT) in psychedelic therapeutics and research and the study of endogenous DMT.N,N-二甲基色胺(DMT)在迷幻治疗学和研究中的给药和内源性 DMT 的研究。
Psychopharmacology (Berl). 2022 Jun;239(6):1749-1763. doi: 10.1007/s00213-022-06065-0. Epub 2022 Jan 22.
9
Chemical Composition of Traditional and Analog Ayahuasca.传统与模拟“阿育吠陀”的化学成分。
J Psychoactive Drugs. 2021 Jan-Mar;53(1):65-75. doi: 10.1080/02791072.2020.1815911. Epub 2020 Sep 8.
10
Ayahuasca: Psychological and Physiologic Effects, Pharmacology and Potential Uses in Addiction and Mental Illness.阿育吠陀:心理和生理效应、药理学以及在成瘾和精神疾病中的潜在用途。
Curr Neuropharmacol. 2019;17(2):108-128. doi: 10.2174/1570159X16666180125095902.

引用本文的文献

1
Psychedelic studies in nonhuman primates: Past and future.非人类灵长类动物的迷幻药研究:过去与未来
Mol Psychiatry. 2025 Sep 12. doi: 10.1038/s41380-025-03240-5.
2
Ayahuasca-assisted meaning reconstruction therapy as an early resource for bereavement: a non-randomized clinical trial.死藤水辅助意义重构疗法作为丧亲之痛的早期资源:一项非随机临床试验。
Sci Rep. 2025 Sep 1;15(1):32158. doi: 10.1038/s41598-025-13251-5.
3
Psychedelics meet human brain organoids: insights into proteomics and potential for Alzheimer's disease treatment.迷幻剂与人类脑类器官:蛋白质组学见解及阿尔茨海默病治疗潜力

本文引用的文献

1
Stem Cells in Psychiatry.精神病学中的干细胞
Adv Exp Med Biol. 2019;1201:159-174. doi: 10.1007/978-3-030-31206-0_8.
2
Therapeutic use of serotoninergic hallucinogens: A review of the evidence and of the biological and psychological mechanisms.血清素能致幻剂的治疗用途:对证据和生物学及心理学机制的综述。
Neurosci Biobehav Rev. 2020 Jan;108:423-434. doi: 10.1016/j.neubiorev.2019.12.001. Epub 2019 Dec 3.
3
Impaired adult neurogenesis is an early event in Alzheimer's disease neurodegeneration, mediated by intracellular Aβ oligomers.
Front Dement. 2025 Aug 4;4:1605051. doi: 10.3389/frdem.2025.1605051. eCollection 2025.
4
Psychoactive substances: novel molecular insights and therapeutic potential for Alzheimer's disease.精神活性物质:对阿尔茨海默病的新分子见解及治疗潜力
Transl Neurodegener. 2025 Jul 25;14(1):38. doi: 10.1186/s40035-025-00498-1.
5
Unveiling GABA and Serotonin Interactions During Neurodevelopment to Re-Open Adult Critical Periods for Neuropsychiatric Disorders.揭示神经发育过程中γ-氨基丁酸(GABA)与血清素的相互作用,以重新开启成人神经精神疾病的关键期。
Int J Mol Sci. 2025 Jun 9;26(12):5508. doi: 10.3390/ijms26125508.
6
Investigating the Synergistic Neuroprotective Effects of Plant-Derived Antioxidants and the Psychedelic N,N-Dimethyltryptamine in Alzheimer's Disease Therapy.研究植物源性抗氧化剂与致幻剂N,N-二甲基色胺在阿尔茨海默病治疗中的协同神经保护作用。
Cells. 2025 Jun 19;14(12):934. doi: 10.3390/cells14120934.
7
Safety, Pharmacokinetics, and Pharmacodynamics of a 6-h N,N-Dimethyltryptamine (DMT) Infusion in Healthy Volunteers: A Randomized, Double-Blind, Placebo-Controlled Trial.健康志愿者中6小时N,N-二甲基色胺(DMT)输注的安全性、药代动力学和药效学:一项随机、双盲、安慰剂对照试验。
Clin Transl Sci. 2025 May;18(5):e70234. doi: 10.1111/cts.70234.
8
From Stress to Synapse: The Neuronal Atrophy Pathway to Mood Dysregulation.从应激到突触:神经元萎缩导致情绪失调的途径。
Int J Mol Sci. 2025 Mar 30;26(7):3219. doi: 10.3390/ijms26073219.
9
The evolution of N, N-Dimethyltryptamine: from metabolic pathways to brain connectivity.N,N-二甲基色胺的演变:从代谢途径到脑连接性
Psychopharmacology (Berl). 2025 Apr 11. doi: 10.1007/s00213-025-06777-z.
10
Psychedelic Drugs in Mental Disorders: Current Clinical Scope and Deep Learning-Based Advanced Perspectives.精神疾病中的迷幻药物:当前临床范围及基于深度学习的前沿观点
Adv Sci (Weinh). 2025 Apr;12(15):e2413786. doi: 10.1002/advs.202413786. Epub 2025 Mar 20.
成年神经发生受损是阿尔茨海默病神经退行性变的早期事件,由细胞内 Aβ 寡聚物介导。
Cell Death Differ. 2020 Mar;27(3):934-948. doi: 10.1038/s41418-019-0409-3. Epub 2019 Oct 7.
4
Ageing as a risk factor for neurodegenerative disease.衰老作为神经退行性疾病的一个风险因素。
Nat Rev Neurol. 2019 Oct;15(10):565-581. doi: 10.1038/s41582-019-0244-7. Epub 2019 Sep 9.
5
A balanced evaluation of the evidence for adult neurogenesis in humans: implication for neuropsychiatric disorders.人类成体神经发生的证据的平衡评估:对神经精神疾病的影响。
Brain Struct Funct. 2019 Sep;224(7):2281-2295. doi: 10.1007/s00429-019-01917-6. Epub 2019 Jul 5.
6
Biosynthesis and Extracellular Concentrations of N,N-dimethyltryptamine (DMT) in Mammalian Brain.哺乳动物脑中 N,N-二甲基色胺(DMT)的生物合成和细胞外浓度。
Sci Rep. 2019 Jun 27;9(1):9333. doi: 10.1038/s41598-019-45812-w.
7
Neurogenesis and antidepressant action.神经发生与抗抑郁作用。
Cell Tissue Res. 2019 Jul;377(1):95-106. doi: 10.1007/s00441-019-03043-5. Epub 2019 Jun 4.
8
Human Hippocampal Neurogenesis Persists in Aged Adults and Alzheimer's Disease Patients.人类海马神经发生在老年人群和阿尔茨海默病患者中持续存在。
Cell Stem Cell. 2019 Jun 6;24(6):974-982.e3. doi: 10.1016/j.stem.2019.05.003. Epub 2019 May 23.
9
Adult hippocampal neurogenesis is abundant in neurologically healthy subjects and drops sharply in patients with Alzheimer's disease.成人海马神经发生在神经健康的个体中较为丰富,而在阿尔茨海默病患者中则急剧下降。
Nat Med. 2019 Apr;25(4):554-560. doi: 10.1038/s41591-019-0375-9. Epub 2019 Mar 25.
10
Depression and adult neurogenesis: Positive effects of the antidepressant fluoxetine and of physical exercise.抑郁与成年神经发生:抗抑郁药氟西汀和体育锻炼的积极影响。
Brain Res Bull. 2018 Oct;143:181-193. doi: 10.1016/j.brainresbull.2018.09.002. Epub 2018 Sep 17.